Key statistics
On Tuesday, ONWARD Medical NV (63E:DUS) closed at 4.21, 14.73% above the 52 week low of 3.67 set on Apr 10, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 4.21 |
|---|---|
| High | 4.21 |
| Low | 4.21 |
| Bid | -- |
| Offer | -- |
| Previous close | 4.17 |
| Average volume | 520.00 |
|---|---|
| Shares outstanding | 56.01m |
| Free float | 46.76m |
| P/E (TTM) | -- |
| Market cap | 234.40m EUR |
| EPS (TTM) | -0.866 EUR |
Data delayed at least 15 minutes, as of Feb 10 2026 07:12 GMT.
More ▼
Announcements
- ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury
- ONWARD Medical Appoints Ali Kiboro as Chief Financial Officer
- ONWARD Medical Completes Two Additional Brain-Computer Interface Implants Paired with Spinal Cord Stimulation Technology to Restore Thought-Driven Movement
- ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025
- ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use
- ONWARD Medical Publishes Closing of Bookbuild Offering
- ONWARD Medical Successfully Raises Over EUR 50 Million in Capital Increase
- ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 50 Million
- ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States
- Portzamparc – Groupe BNP Paribas initie la couverture d’ONWARD Medical avec une recommandation d’Achat et un objectif de cours de 10,20 EUR
More ▼
